Cytokinetics
CYTK
#2280
Rank
$8.02 B
Marketcap
$65.67
Share price
-1.31%
Change (1 day)
30.30%
Change (1 year)

Cytokinetics (CYTK) - Total debt

Total debt on the balance sheet as of September 2025 : $1.19 Billion USD

According to Cytokinetics 's latest financial reports the company's total debt is $1.19 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Cytokinetics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$0.78 B4.35%
2023-12-31$0.75 B0.73%
2022-12-31$0.75 B177.96%
2021-12-31$0.26 B94.28%
2020-12-31$0.13 B2.11%
2019-12-31$0.13 B215.09%
2018-12-31$43.18 M35.9%
2017-12-31$31.77 M6.35%
2016-12-31$29.88 M104.12%
2015-12-31$14.63 M
2012-12-31N/A-100%
2011-12-31$0.15 M-84.57%
2010-12-31$0.98 M-92.31%
2009-12-31$12.8 M175.91%
2008-12-31$4.64 M-46.6%
2007-12-31$8.68 M-19.81%
2006-12-31$10.83 M15.73%
2005-12-31$9.36 M-10.78%
2004-12-31$10.49 M4.07%
2003-12-31$10.08 M6.23%
2002-12-31$9.49 M169.28%
2001-12-31$3.52 M226.69%
2000-12-31$1.07 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Ligand Pharmaceuticals
LGND
$0.45 B-62.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
$37.56 M-96.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
$0.19 B-83.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$54.58 B 4,460.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
$0.68 B-43.10%๐Ÿ‡บ๐Ÿ‡ธ USA